SHATTUCK LABS INC. - COMMON STOCK

Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors

04 3 2024 06:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights

29 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming March Conferences

26 2 2024 06:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases

13 2 2024 05:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024

08 1 2024 06:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare Conference

04 1 2024 15:05:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded Warrants

21 12 2023 07:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients

13 12 2023 05:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation Data from the American Society of Hematology (ASH) 2023 Annual Meeting on December 13, 2023

05 12 2023 15:15:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx Conference

14 11 2023 08:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business Highlights

09 11 2023 05:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023

06 11 2023 08:28:40 提供 Nasdaq GlobeNewswire

Shattuck Labs to Present Topline Data from Phase 1 A/B Clinical Trial of SL-172154 in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Higher-Risk Myelodysplastic Syndromes (HR-MDS) Patients at the American Society of Hematology (ASH) 2023 Annual Meeting

02 11 2023 08:01:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Reports Second Quarter 2023 Financial Results and Recent Business Highlights

10 8 2023 15:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs to Present Complete Dose-Escalation Data from Phase 1A Monotherapy Clinical Trial of SL-172154 in Platinum-Resistant Ovarian Cancer (PROC) at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting

25 5 2023 16:15:39 提供 Nasdaq GlobeNewswire

Shattuck Labs Reports First Quarter 2023 Financial Results and Recent Business Highlights

09 5 2023 15:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming 22nd Annual Needham Virtual Healthcare Conference

03 4 2023 06:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Presents Preclinical Data at the 2023 American Association for Cancer Research (AACR) Annual Meeting

16 3 2023 07:31:26 提供 Nasdaq GlobeNewswire

Shattuck Labs Announces Participation in Upcoming March Conferences

01 3 2023 06:00:00 提供 Nasdaq GlobeNewswire

Shattuck Labs Reports Fourth-Quarter and Full-Year 2022 Financial Results and Provides Business Updates

23 2 2023 15:30:00 提供 Nasdaq GlobeNewswire